Showing 1-10 of 3092 results for "".
- Emma Guttman-Yassky, MD, PhDhttps://practicaldermatology.com/profiles/emma-guttman-yassky-md-phd/OEmRP8/Emma Guttman-Yassky, MD, PhD, Professor of Dermatology and Immunology, Vice Chair of the Department of Dermatology, Director of the Center for Excellence in Eczema, and the Laboratory of Inflammatory Skin Diseases at the Icahn School of Medicine at Mount Sinai Medical Center, New York. She earned h…
Close Up With Emma Guttman-Yassky, MD, PhD
https://practicaldermatology.com/topics/close-up/close-up-with-emma-guttman-yassky-md-phd/23953/- Emma Guttman-Yassky, MD, PhDhttps://practicaldermatology.com/profiles/emma-guttman-yassky-md-phd/Ow5M0a/
- Emma Guttman-Yassky MD, PhDhttps://practicaldermatology.com/profiles/emma-guttman-yassky-md-phd/jPw3VK/
- New York’s Mount Sinai Health System Names New Chair of Dermatology and New Dean For Clinical Therapeuticshttps://practicaldermatology.com/news/new-yorks-mount-sinai-health-system-names-new-chair-of-dermatology-and-new-dean-for-clinical-therapeutics/2460486/Emma Guttman-Yassky, MD, PhD, is the new Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. She will be the first woman to serve as Chair of a Department of Dermatology in New York City. S
- Keloid Breakthrough: Mount Sinai Researchers Show Keloid Shrinkage with Dupilumabhttps://practicaldermatology.com/news/keloid-breakthrough-mount-sinai-researchers-show-keloid-shrinkage-with-dupilumab/2460223/Keloid lesions exhibit increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy, Mount Sinai researchers report. Researchers, led by Emma Guttman-Yassky, MD, PhD, Vice Chair, Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York,
Journal Club: A Comprehensive Update
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-a-comprehensive-update/32402/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the recent Lancet article "Atopic Dermatitis" with primary author Emma Guttman, MD, PhD. Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405(10478):583-596. doi: 10.1016/S0140-6736(24)0Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20825/The Role for Rinvoq in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/the-role-for-rinvoq-in-ad-care/23663/One of the first oral JAK inhibitors approved in dermatology expands options for moderate to severe AD.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-27/23585/
- Prev
- Next